RISK OF THERAPY-RELATED LEUKAEMIA AND PRELEUKAEMIA AFTER HODGKIN'S DISEASE Relation to Age, Cumulative Dose of Alkylating Agents, and Time from Chemotherapy

[1]  J. Pedersen‐Bjergaard,et al.  Cytogenetic characteristics of therapy‐related acute nonlymphocytic leukaemia, preleukaemia and acute myeloproliferative syndrome: correlation with clinical data for 61 consecutive cases , 1987, British journal of haematology.

[2]  L. Melton,et al.  Melphalan may be a more potent leukemogen than cyclophosphamide. , 1986, Annals of internal medicine.

[3]  A. Santoro,et al.  Second acute leukemia and other malignancies following treatment for Hodgkin's disease. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  T. Lister,et al.  Second primary malignant neoplasms in patients treated for hodgkin's disease at st bartholomew's hospital , 1986, Hematological oncology.

[5]  R. Larson,et al.  Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  J. Bertino,et al.  Second neoplasms in patients with Hodgkin's disease following combined modality therapy--the Yale experience. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  M. Greene,et al.  Leukemia after adjuvant chemotherapy with semustine (methyl-CCNU)--evidence of a dose-response effect. , 1986, The New England journal of medicine.

[8]  J. Pedersen‐Bjergaard,et al.  Acute nonlymphocytic leukemia, preleukemia, and solid tumors following intensive chemotherapy of small cell carcinoma of the lung , 1985 .

[9]  H. Rockette,et al.  Leukemia in breast cancer patients following adjuvant chemotherapy or postoperative radiation: the NSABP experience. , 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  N Keiding,et al.  Risk of acute nonlymphocytic leukemia and preleukemia in patients treated with cyclophosphamide for non-Hodgkin's lymphomas. Comparison with results obtained in patients treated for Hodgkin's disease and ovarian carcinoma with other alkylating agents. , 1985, Annals of internal medicine.

[11]  F. Greco,et al.  Lung cancer in Hodgkin's disease: association with previous radiotherapy. , 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  C. N. Coleman,et al.  Cutaneous malignant melanoma after Hodgkin's disease. , 1985, Annals of internal medicine.

[13]  J. Godbold,et al.  Leukemia following treatment of germ cell tumors in men. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  P. Mazza,et al.  Acute leukaemia in patients treated for Hodgkin's disease , 1984, British journal of haematology.

[15]  N. Nissen,et al.  Acute nonlymphocytic leukemia, preleukemia, and acute myeloproliferative syndrome secondary to treatment of other malignant diseases. II. Bone marrow cytology, cytogenetics, results of HLA typing, response to antileukemic chemotherapy, and survival in a total series of 55 patients , 1984, Cancer.

[16]  R. Makuch,et al.  Second malignant neoplasms complicating Hodgkin's disease: the National Cancer Institute experience. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  M. Tucker,et al.  Increased incidence of acute nonlymphocytic leukemia following therapy in patients with small cell carcinoma of the lung. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  C. Jacquillat,et al.  Non‐Hodgkin's lymphoma occurring after hodgkin's disease four new cases and a review of the literature , 1984, Cancer.

[19]  R J Keehn,et al.  Leukemia and preleukemia after adjuvant treatment of gastrointestinal cancer with semustine (methyl-CCNU). , 1983, The New England journal of medicine.

[20]  M. Henry-Amar.  Second cancers after radiotherapy and chemotherapy for early stages of Hodgkin's disease. , 1983, Journal of the National Cancer Institute.

[21]  A. Aisenberg.  Acute nonlymphocytic leukemia after treatment for Hodgkin's disease. , 1983, The American journal of medicine.

[22]  M. Greene,et al.  Evidence of a treatment dose response in acute nonlymphocytic leukemias which occur after therapy of non-Hodgkin's lymphoma. , 1983, Cancer research.

[23]  J. Armitage,et al.  Second lymphoid malignant neoplasms occurring in patients treated for Hodgkin's disease. , 1983, Archives of internal medicine.

[24]  M. Greene,et al.  Acute nonlymphocytic leukemia after therapy with alkylating agents for ovarian cancer: a study of five randomized clinical trials. , 1982, The New England journal of medicine.

[25]  J. Cuzick,et al.  Long‐term survival in myelomatosis; A REPORT TO THE MRC WORKING PARTY ON LEUKAEMIA IN ADULTS , 1982, British journal of haematology.

[26]  S. Larsen,et al.  Incidence of acute nonlymphocytic leukemia, preleukemia, and acute myeloproliferative syndrome up to 10 years after treatment of Hodgkin's disease. , 1982, The New England journal of medicine.

[27]  Coltman Ca,et al.  Second malignancies complicating Hodgkin's disease: a Southwest Oncology Group 10-year followup. , 1982 .

[28]  C. Coleman.  Leukemias, non-Hodgkin's lymphomas and solid tumors in patients treated for Hodgkin's disease , 1982 .

[29]  J. Aisner,et al.  Lung cancer as a complication of prolonged survival in patients with lymphoma. , 1982, Medical and pediatric oncology.

[30]  J. Boivin,et al.  Leukemia and other cancers after radiotherapy and chemotherapy for Hodgkin's disease. , 1981, Journal of the National Cancer Institute.

[31]  J. Pedersen‐Bjergaard,et al.  Acute nonlymphocytic leukemia, preleukemia, and acute myeloproliferative syndrome secondary to treatment of other malignant diseases. Clinical and cytogenetic characteristics and results of in vitro culture of bone marrow and HLA typing. , 1981, Blood.

[32]  J. Goldberg,et al.  Increased incidence of acute leukemia in polycythemia vera associated with chlorambucil therapy. , 1981, The New England journal of medicine.

[33]  M. Baccarani,et al.  Second malignancy in patients treated for Hodgkin's disease , 1980 .

[34]  N. Nissen,et al.  Acute non‐lymphocytic leukemia in patients with ovarian carcinoma following long‐term treatment with treosulfan (=dihydroxybusulfan) , 1980, Cancer.

[35]  A. Miller,et al.  The chemotherapy on plasma-cell myeloma and the incidence of acute leukemia. , 1979, The New England journal of medicine.

[36]  S. Rosenberg,et al.  Occurrence of non-Hodgkin's lymphoma after therapy for Hodgkin's disease. , 1979, The New England journal of medicine.

[37]  D. Girling,et al.  Acute leukaemia after busulphan. , 1977, British medical journal.

[38]  R. Hoover,et al.  Acute leukemia after alkylating-agent therapy of ovarian cancer. , 1977, The New England journal of medicine.

[39]  M. Pike,et al.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. , 1977, British Journal of Cancer.

[40]  David R. Cox,et al.  Regression models and life tables (with discussion , 1972 .

[41]  M Tubiana,et al.  Report of the Committee on Hodgkin's Disease Staging Classification. , 1971, Cancer research.

[42]  D. Catovsky,et al.  Myelomonocytic leukaemia supervening on chronic lymphocytic leukaemia. , 1971, Lancet.

[43]  L. Craver,et al.  Report of the Nomenclature Committee , 1966 .

[44]  M. Tomonaga,et al.  Leukemia in man following exposure to ionizing radiation. A summary of the findings in Hiroshima and Nagasaki, and a comparison with other human experience. , 1962, Annals of internal medicine.

[45]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .